Dietary Supplement for Myopia Control

Starting soon · Not applicable · Has a placebo group

Conditions studied: Myopia

In brief

The purpose of this clinical trial is to investigate the changes in choroidal thickness and vasculature in myopic children following oral supplementation.

Key facts

Study ID

NCT07406906

Run by

The Hong Kong Polytechnic University

People needed

156

Starts

2026-08-01

Expected to finish

2026-12-30

Last updated by the study team

2026-07-24

Who can join

Age: 8 and older, up to 13. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 8-13 years
• Cycloplegic spherical equivalent refraction (SER) of -0.50 D to -5.00 D with astigmatism of 2.5 D or less and best-corrected visual acuity (BCVA) of 0.0 logarithm or more in either eye
• Anisometropia of 1.50 D or less
• Intraocular pressure of 10 mmHg to 21 mmHg in both eyes
• Willing to give written consent to participate in the study and accept random allocation in grouping

You may not qualify if…

• Ocular abnormalities leading to visual impairment
• Severe physiological and psychological diseases affecting follow-up
• Receiving previous myopia control treatment including but not limited to atropine therapy and orthokeratology in the past 3 months
• Use of any other dietary supplements containing DHA/EPA, Lutein, or Astaxanthin in the past 3 months
• Known history of allergy to any of the components of the dietary supplement or placebo, or history of an allergic reaction that required emergency treatment
• Children who had other contraindications identified by the investigators that made them unsuitable for participation

Where it is running

• Hong Kong Polytechnic University — Hong Kong, Hong Kong

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.